Flerie Invest
Investor profile
Deals
7
distinct rounds
Companies
6
backed
Active span
2020–2023
4 yrs
Total round €
€125M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Thuja Capital2
- 3B Health Ventures1
- ABC Ventures1
- British Patient Capital1
- C4 Ventures1
- Cambridge Innovation Capital1
- European Innovation Council (EIC)1
- Fredrik and Ann-Helene Ljungström1
- Iðunn Venture Fund1
- Industrifonden1
- InnovationQuarter1
- IP Group1
- Karolinska Development1
- Netherlands Enterprise Agency1
- RVO.nl1
- Seventure Partners1
- Tencent1
- Utrecht Health Seed Fund1
- Utrecht Holdings1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Microbiotica | UK | 1 | €61M |
| EpiEndo Pharmaceuticals | Iceland | 1 | €20M |
| KAHR Medical | Israel | 1 | €17M |
| AnaCardio | Sweden | 1 | €14M |
| Synerkine Pharma | Netherlands | 2 | €8.8M |
| Amarna Therapeutics | Netherlands | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Microbiotica | Series B | €61M | 2022-03 |
| EpiEndo Pharmaceuticals | Series A | €20M | 2021-08 |
| KAHR Medical | Series D+ | €17M | 2020-02 |
| AnaCardio | Series A | €14M | 2022-09 |
| Synerkine Pharma | Series A | €5.3M | 2023-10 |
| Amarna Therapeutics | Other | €5.0M | 2021-12 |
| Synerkine Pharma | Series A | €3.5M | 2021-12 |